News

1:11 AMYahoo Finance

Acadia Pharmaceuticals fell while sales rose

ACAD−1.3%

11:47 PMYahoo Finance

Acadia Pharmaceuticals comments on Federal Circuit Oral Argument in NUPLAZID® formulation patent appeal

ACAD−1.3%

11:29 PMYahoo Finance

Acadia Pharmaceuticals (ACAD) stock still looks like a bargain today

ACAD−1.3%

8:17 PMYahoo Finance

Acadia Pharmaceuticals (ACAD) cuts 2026 R and D guidance, is it still 46% undervalued?

ACAD−1.3%

4:05 PMYahoo Finance

Acadia Pharmaceuticals to present remlifanserin data at the 2026 Clinical Trials on Alzheimer's Disease (CTAD) Conference

ACAD−1.3%

12:07 PMYahoo Finance

Acadia Pharmaceuticals sees Continued Daybue momentum in Q3, RBC says

ACAD−1.3%

8:14 PMYahoo Finance

What ACADIA Pharmaceuticals (ACAD) said on its Q3 earnings call

ACAD−1.3%

6:45 PMYahoo Finance

Acadia Pharmaceuticals (ACAD) tops Q3 earnings and revenue estimates

ACAD−1.3%

4:57 PMYahoo Finance

Acadia: Q3 earnings snapshot

ACAD−1.3%

4:05 PMYahoo Finance

Acadia Pharmaceuticals reports third quarter 2026 financial results

ACAD−1.3%

4:05 PMYahoo Finance

Acadia Pharmaceuticals to participate in the UBS Global Biopharma Conference 2026

ACAD−1.3%

9:00 AMYahoo Finance

Earnings preview: Acadia Pharmaceuticals (ACAD) Q3 earnings expected to decline

ACAD−1.3%